The University of Chicago Header Logo
Last Name


Robert Naclerio to Glucocorticoids

This is a "connection" page, showing publications Robert Naclerio has written about Glucocorticoids.

Connection Strength
  1. Luskin AT, Blaiss MS, Farrar JR, Settipane R, Hayden ML, Stoloff S, Chadwick SJ, Derebery MJ, Ettari MP, Luskin S, Naclerio R. Is there a role for aerosol nasal sprays in the treatment of allergic rhinitis: a white paper. Allergy Asthma Proc. 2011 Mar-Apr; 32(2):168-77.
    View in: PubMed
    Score: 0.384
  2. Naclerio R. Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis. Otolaryngol Head Neck Surg. 2008 Feb; 138(2):129-39.
    View in: PubMed
    Score: 0.311
  3. Baroody FM, Rouadi P, Driscoll PV, Bochner BS, Naclerio RM. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation. Am J Respir Crit Care Med. 1998 Mar; 157(3 Pt 1):899-906.
    View in: PubMed
    Score: 0.156
  4. Brown K, Lane J, Silva MP, DeTineo M, Naclerio RM, Baroody FM. A pilot study of the effects of intranasal budesonide delivered by NasoNebĀ® on patients with perennial allergic rhinitis. Int Forum Allergy Rhinol. 2014 Jan; 4(1):43-8.
    View in: PubMed
    Score: 0.117
  5. Baroody FM, Cheng CC, Moylan B, deTineo M, Haney L, Reed KD, Cook CK, Westlund RE, Sengupta E, Corey JP, Togias A, Naclerio RM. Absence of nasal mucosal atrophy with fluticasone aqueous nasal spray. Arch Otolaryngol Head Neck Surg. 2001 Feb; 127(2):193-9.
    View in: PubMed
    Score: 0.048
  6. Naclerio RM, deTineo ML, Baroody FM. Ragweed allergic rhinitis and the paranasal sinuses. A computed tomographic study. Arch Otolaryngol Head Neck Surg. 1997 Feb; 123(2):193-6.
    View in: PubMed
    Score: 0.036
  7. Freeland HS, Pipkorn U, Schleimer RP, Bascom R, Lichtenstein LM, Naclerio RM, Peters SP. Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol. 1989 Mar; 83(3):634-42.
    View in: PubMed
    Score: 0.021
  8. Naclerio RM. The pathophysiology of allergic rhinitis: impact of therapeutic intervention. J Allergy Clin Immunol. 1988 Nov; 82(5 Pt 2):927-34.
    View in: PubMed
    Score: 0.020
  9. Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. 1987 Jun 11; 316(24):1506-10.
    View in: PubMed
    Score: 0.019
  10. Naclerio RM, Kagey-Sobotka A, Lichtenstein LM, Togias AG, Iliopoulos O, Pipkorn U, Bascom R, Norman PS, Proud D. Observations on nasal late phase reactions. Immunol Invest. 1987-1988 Dec; 16(8):649-85.
    View in: PubMed
    Score: 0.018
  11. Bousquet J, Van Cauwenberge P, Bachert C, Canonica GW, Demoly P, Durham SR, Fokkens W, Lockey R, Meltzer EO, Mullol J, Naclerio RM, Price D, Simons FE, Vignola AM, Warner JO. Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy. 2003 Mar; 58(3):192-7.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.